| NDC Code | 43742-0434-1 |
|---|
| Package Description | 30 mL in 1 BOTTLE, DROPPER (43742-0434-1) |
|---|
| Product NDC | 43742-0434 |
|---|
| Product Type Name | HUMAN OTC DRUG |
|---|
| Proprietary Name | Rheumatoid Arthritis Nosode |
|---|
| Non-Proprietary Name | Atp (adenosine Triphosphate Disodium), Malic Acid, Natrum Oxalaceticum, Riboflavinum, Apiolum, Cinnamic Acid, Dhea (dehydroepiandrosterone), Streptococcus Viridans |
|---|
| Dosage Form | LIQUID |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20140711 |
|---|
| End Marketing Date | 20221130 |
|---|
| Marketing Category Name | UNAPPROVED HOMEOPATHIC |
|---|
| Manufacturer | Deseret Biologicals, Inc. |
|---|
| Substance Name | ADENOSINE TRIPHOSPHATE DISODIUM; APIOLE (PARSLEY); BORRELIA BURGDORFERI; BRUCELLA ABORTUS; CAMPYLOBACTER JEJUNI; CHLAMYDIA TRACHOMATIS; CINNAMIC ACID; ENTEROCOCCUS FAECALIS; KLEBSIELLA PNEUMONIAE; MALIC ACID; MYCOPLASMA PNEUMONIAE; OROTIC ACID MONOHYDRATE; OYSTER SHELL CALCIUM CARBONATE, CRUDE; PRASTERONE; PROTEUS MORGANII; RIBOFLAVIN; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR ENTERITIDIS; SHIGELLA DYSENTERIAE; SHIGELLA SONNEI; SODIUM DIETHYL OXALACETATE; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS DYSGALACTIAE; STREPTOCOCCUS EQUINUS; STREPTOCOCCUS MUTANS; STREPTOCOCCUS PNEUMONIAE; STREPTOCOCCUS PYOGENES; STREPTOCOCCUS UBERIS; STREPTOCOCCUS VIRIDANS GROUP; YERSINIA ENTEROCOLITICA |
|---|
| Strength | 6; 6; 15; 15; 15; 15; 6; 13; 15; 6; 15; 6; 15; 6; 30; 6; 14; 15; 15; 6; 9; 15; 32; 13; 17; 15; 15; 12; 17 |
|---|
| Strength Unit | [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_C]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL |
|---|